The Beneficial Effects of Combining Anti-Aβ Antibody NP106 and Curcumin Analog TML-6 on the Treatment of Alzheimer’s Disease in APP/PS1 Mice

The Beneficial Effects of Combining Anti-Aβ Antibody NP106 and Curcumin Analog TML-6 on the Treatment of Alzheimer’s Disease in APP/PS1 Mice

Alzheimer’s disease (AD) is a progressive neurodegenerative disease with a multifactorial etiology. A multitarget treatment that modulates multifaceted biological functions might be more effective than a single-target approach. Here, the therapeutic efficacy of combination treatment using anti-Aβ an...

Full description

Bibliographic Details
Main Authors: Ih-Jen Su, Chia-Yu Hsu, Santai Shen, Po-Kuan Chao, John Tsu-An Hsu, Jung-Tsung Hsueh, Jia-Jun Liang, Ying-Ting Hsu, Feng-Shiun Shie
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:International Journal of Molecular Sciences
Subjects:
Alzheimer’s disease
combination treatment
anti-Aβ immunotherapy
microglial phagocytosis
inflammation
gut microbiota
Online Access:https://www.mdpi.com/1422-0067/23/1/556

Internet

https://www.mdpi.com/1422-0067/23/1/556

Similar Items